FDA Inspection 1249056 — Cedars-Sinai Center For Fertility And Reproductive Medicine
The FDA completed an inspection of Cedars-Sinai Center For Fertility And Reproductive Medicine on Sep 5, 2024 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 5, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Los Angeles, CA (United States)